Gene Fusions

All
Insights
Investors
Board of Directors
Leadership
Uncategorized
Our Partners
Scientific Advisory Committee
Publications
Newsroom

June 07, 2022

Posters & Oral Presentations

CRESTONE: Initial Efficacy and Safety of Seribantumab in Solid Tumors Harboring NRG1 Fusions

Presented at 2022 ASCO Annual Meeting

Presenting Author: Daniel R. Carrizosa, MD

Read More

October 14, 2021

Posters & Oral Presentations

Comprehensive genomic profiling reveals novel opportunities for treatment-refractory gastrointestinal cancers

Presented at AGITG 2021

Wei Yen Chan, The Kinghorn Cancer Centre, St. Vincent’s Hospital, Sydney

Read More

April 10, 2021

Posters & Oral Presentations

Preclinical activity of seribantumab in gastrointestinal cancers with NRG1 fusions

Presented at AACR 2021

Presenting Author: Igor Odintsov, MD; Memorial Sloan Kettering Cancer Center

Read More

April 06, 2021

Manuscripts

The anti-HER3 monoclonal antibody seribantumab effectively inhibits growth of patient-derived and isogenic cell line and xenograft models with oncogenic NRG1 fusions

Odintsov et al., Clinical Cancer Research 2021

Read More

February 22, 2021

Infographic: PDX Models and Precision Oncology Read More

February 22, 2021

Genomic Testing for Cancer Read More

Pages: 12